# Appco Pharma LLC – FDA Inspection, May 14, 2026

Source: https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/70fc121e-d60a-4e25-8d7e-ed5942f9a4f0
Source feed: FDA_Inspections

> FDA inspection 1301504 of Appco Pharma LLC, May 14, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1301504
- Company Name: Appco Pharma LLC
- Inspection Date: 2026-05-14
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 5

## Related Documents

- [FDA Inspection 1232512 - 2024-03-11](https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/b847f1fe-c466-48a8-8cad-d077d6a1104d)
- [FDA Inspection 1216223 - 2023-08-29](https://www.keypedia.com/records/fda_inspections/appco-pharma-llc/773429a4-2a26-471f-8bf2-77c3a2f2fdef)
- FDA Inspection 1179037 - 2022-08-19
- FDA Inspection 1122406 - 2020-03-27
- FDA Inspection 1093238 - 2019-05-28

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/james-r-birkenstamm/eb1192a4-3c76-4243-886c-9b5805871ad1)

Company: https://www.keypedia.com/companies/appco-pharma-llc/b4a77ba5-0e8a-47ae-94c2-951f5a0b2100

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248